Advertisement

Topics

Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors

05:03 EDT 19 Jun 2017 | Labiotech.eu

Celyad has announced no toxicity and stable disease in colorectal cancer patients after just 3 months of its first trial testing CAR-T in solid tumors. After only 3 months of follow-up, Celyad already has positive results for its CAR-T NKR-2 therapy, ...

This awesome article Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors

NEXT ARTICLE

More From BioPortfolio on "Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...